Physician profile
Nilofer Nisar
NPI 1922094564
$4,012.80
in general payments reported to CMS, 2019-2025
45 companies · $18.84 in 2025
The $18.84 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,197 · 2020: $819 · 2021: $665 · 2022: $979 · 2023: $286 · 2024: $47.27 · 2025: $18.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $608.14 | 2021-2024 | Zeposia |
| Eisai INC. | $372.93 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $331.17 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $302.16 | 2019-2021 | |
| Abbvie INC. | $252.41 | 2021-2023 | |
| Mdd US Operations, LLC | $250.95 | 2019-2020 | |
| Allergan, INC. | $227.81 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $145.50 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $111.71 | 2019-2020 | |
| Argenx US, INC. | $102.91 | 2022-2023 | Vyvgart |
| Sk Life Science, INC. | $90.32 | 2020-2021 | |
| Pfizer INC. | $85.26 | 2019-2022 | |
| Amgen INC. | $76.53 | 2019-2022 | |
| Horizon Therapeutics Plc | $73.69 | 2022 | |
| Neurelis, INC. | $70.40 | 2020 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilofer Nisar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.